The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future
Tseng, A., Seet, J. and Phillips, E.J. (2015) The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future. British Journal of Clinical Pharmacology, 79 (2). pp. 182-194.
*No subscription required
The evolution of HIV treatment has improved our understanding and management of complex pharmacological issues that have driven improved outcomes and quality of life of the HIV-infected patient. These include adherence, long and short-term toxicities, pharmacoenhancement, pharmacogenomics, therapeutic drug monitoring (TDM), differential penetration of drugs into sanctuary sites such as the central nervous system (CNS), genital tract and small bowel and drug-drug and drug-food interactions related to cytochrome P450 drug metabolizing enzymes, UGT1A1 and drug transporters to name a few. There is future promise as an increased understanding of the immunopathogenesis of HIV and global public health initiatives are driving novel treatment approaches with goals to prevent, control and ultimately eradicate HIV.
|Publication Type:||Journal Article|
|Murdoch Affiliation:||Institute for Immunology and Infectious Diseases|
|Copyright:||© 2014 The British Pharmacological Society|
|Item Control Page|
Downloads per month over past year